Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Ondoa

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
PLOS Global Public Health|May 18, 2023
Contexts for developing of national essential diagnostics lists. Lessons from a mixed-methods study of existing documents, stakeholders and decision making on tier-specific essential in-vitro diagnostics in African countriesWinny Koster, Elishebah Maruta Mutegi, Francis Ocen, et al.
African Journal of Laboratory Medicine|December 21, 2018
Africa Centres for Disease Control and Prevention's framework for antimicrobial resistance control in AfricaJay K Varma, John Oppong-Otoo, Pascale Ondoa, et al.
The Journal of Infectious Diseases|May 16, 2019
Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral TherapyStefanie Kroeze, Ferdinand W Wit, Theresa M Rossouw, et al.
Journal of the International AIDS Society|November 13, 2016
High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian childrenRagna S Boerma, T Sonia Boender, Kim C E Sigaloff, et al.
The Journal of Infectious Diseases|December 29, 2020
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral TherapyStefanie Kroeze, Theresa M Rossouw, Helen C Steel, et al.
AIDS (London, England)|February 1, 2024
Specific plasma microRNAs are associated with CD4 + T-cell recovery during suppressive antiretroviral therapy for HIV-1Stefanie Kroeze, Neeltje A Kootstra, Ad C van Nuenen, et al.
Scientific Reports|October 27, 2018
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistanceSeth C Inzaule, Cissy M Kityo, Margaret Siwale, et al.
AIDS (London, England)|July 18, 2020
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan AfricaSeth C Inzaule, Silvia Bertagnolio, Cissy M Kityo, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2016
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan AfricaT Sonia Boender, Cissy M Kityo, Ragna S Boerma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2023
CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual)Hea Sun Joh, Brooke Dolabella, Emmanuel Early, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
PLOS Global Public Health|May 18, 2023
Contexts for developing of national essential diagnostics lists. Lessons from a mixed-methods study of existing documents, stakeholders and decision making on tier-specific essential in-vitro diagnostics in African countriesWinny Koster, Elishebah Maruta Mutegi, Francis Ocen, et al.
African Journal of Laboratory Medicine|December 21, 2018
Africa Centres for Disease Control and Prevention's framework for antimicrobial resistance control in AfricaJay K Varma, John Oppong-Otoo, Pascale Ondoa, et al.
The Journal of Infectious Diseases|May 16, 2019
Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral TherapyStefanie Kroeze, Ferdinand W Wit, Theresa M Rossouw, et al.
Journal of the International AIDS Society|November 13, 2016
High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian childrenRagna S Boerma, T Sonia Boender, Kim C E Sigaloff, et al.
The Journal of Infectious Diseases|December 29, 2020
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral TherapyStefanie Kroeze, Theresa M Rossouw, Helen C Steel, et al.
AIDS (London, England)|February 1, 2024
Specific plasma microRNAs are associated with CD4 + T-cell recovery during suppressive antiretroviral therapy for HIV-1Stefanie Kroeze, Neeltje A Kootstra, Ad C van Nuenen, et al.
Scientific Reports|October 27, 2018
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistanceSeth C Inzaule, Cissy M Kityo, Margaret Siwale, et al.
AIDS (London, England)|July 18, 2020
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan AfricaSeth C Inzaule, Silvia Bertagnolio, Cissy M Kityo, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2016
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan AfricaT Sonia Boender, Cissy M Kityo, Ragna S Boerma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2023
CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual)Hea Sun Joh, Brooke Dolabella, Emmanuel Early, et al.
Pageof 8